PACK EXPO Las Vegas grows alongside the industry

 

The twentieth anniversary edition of PACK EXPO Las Vegas, held at the Las Vegas Convention Center on 28th to 30th September should be the largest yet, predicts show owner and producer PMMI, The Association for Packaging and Processing Technologies.

While its more than 800,000 net square feet of exhibit space is significant, PMMI also anticipates visitor attendance near 30,000 and over two thousand exhibitors. These industry leaders serve more than 40 vertical markets, an indicator of PACK EXPO Las Vegas’ growth in breadth and depth over the years. The expansion includes the Las Vegas debut of Pharma EXPO, jointly produced by PMMI and the International Society for Pharmaceutical Engineering.

Charles D Yuska, president and CEO, PMMI, says, “PACK EXPO shows have evolved alongside the needs of attendees and exhibitors, and we’ve come a long way from where we started. Today, PACK EXPO trade shows are always the year’s most comprehensive events for packaging innovation. In the case of PACK EXPO Las Vegas, it’s been a quick jump from regional show to expansive, must-attend event.”

In 1995, PMMI introduced the industry to PACK EXPO West, featuring packaging equipment from 532 exhibitors and attracting 9334 attendees. Exhibit space was about 200,000 net square feet — about 25% of this year’s event. The international flavour of the show has grown as well, with visitors from outside the United States making up 8.3% of the attendee base in 1995 and 18% at the most recent edition, in 2013. The number of international exhibitors also increased from just 54 at the debut event to more than 310 showcasing solutions this year in Las Vegas.

The co-location of Pharma EXPO brings that point home, focusing on supply chain solutions for the pharmaceutical, biopharmaceutical, nutraceutical and medical device industries. The combination of the two shows also presents the opportunity to explore a wide range of industries and ideas.

Brian Barr, packaging systems sales manager, Heat and Control, one of the original exhibitors that will be at this year’s show, says, “PACK EXPO has evolved to serve the broad needs of a diverse market that has packaging as its nucleus. From equipment for food processing, to conveying, packaging, and inspection, this show provides a single forum for presenting and discussing solutions. As a full-service supplier, we need a full-service trade show where our customers can discuss a range of projects at a single location. PACK EXPO is that single source where we can communicate all our products and services to our customers.”

As the event has grown, PMMI has also added customer-centric features designed to help attendees maximise their time on the show floor and leverage networking opportunities. Industry-specific lounges and specialised pavilions like The Brand Zone and provide quick access to the latest developments in specific market niches.

For more information and to register, visit packexpolasvegas.com.

 

 

 

A message from the Editor:

Thank you for reading this story on our news site - please take a moment to read this important message:

As you know, our aim is to bring you, the reader, an editorially led news site but journalism costs money and we rely on advertising and digital revenues to help to support them.

With the Covid-19 lockdown having a major impact on our industry as a whole, the advertising revenues we normally receive, which helps us cover the cost of our journalists and this website, have been drastically affected.

As such we need your help. If you can support our news sites with a small donation of even £1, your generosity will help us weather the storm and continue in our quest to deliver quality journalism.

In the meantime may I wish you the very best.

- Advertisement -

Brilinta approved in US to reduce the risk of first heart attack or stroke

AstraZeneca’s Brilinta (ticagrelor) has been approved in the US to reduce the risk of a first heart attack or stroke in high-risk patients with...

GSK to manufacture 1bn doses of pandemic vaccine

GlaxoSmithKline (GSK) is aiming to manufacture one billion doses of its pandemic vaccine adjuvant system, in 2021, to support the development of multiple adjuvanted...

Chimeron Bio & NCBID to develop COVID-19 vaccine

RNA therapeutics company, Chimeron Bio, and George Mason University’s National Center for Biodefense and Infectious Diseases (NCBID), will together develop a COVID-19 vaccine. The vaccine...

AbCellera raises $105m to advance antibody drug discovery platform

AbCellera has closed a $105 million Series B financing to further advance its antibody drug discovery platform. The financing was led by OrbiMed and current...

Novavax expands large-scale manufacturing capacity

Novavax, a late-stage biotech developing next-gen vaccines for serious infectious diseases, has expanded its large-scale manufacturing capacity with the $167 million acquisition of Praha...

Related news

Emergent joins partnership for COVID-19 vaccine development & manufacturing

Emergent BioSolutions has been issued a task order under an existing contract with the Biomedical Advanced Research and Development Authority (BARDA) to deploy its...

Brilinta approved in US to reduce the risk of first heart attack or stroke

AstraZeneca’s Brilinta (ticagrelor) has been approved in the US to reduce the risk of a first heart attack or stroke in high-risk patients with...

GSK to manufacture 1bn doses of pandemic vaccine

GlaxoSmithKline (GSK) is aiming to manufacture one billion doses of its pandemic vaccine adjuvant system, in 2021, to support the development of multiple adjuvanted...

Chimeron Bio & NCBID to develop COVID-19 vaccine

RNA therapeutics company, Chimeron Bio, and George Mason University’s National Center for Biodefense and Infectious Diseases (NCBID), will together develop a COVID-19 vaccine. The vaccine...